老年人的慢性炼和执行功能 - 综合认知和运动炼的宝藏
Bettina Wollesen1, Claudia Voelcker-Rehage2
1Institute of Movement Therapy and Movement-oriented Prevention and Rehabilitation, German Sportsuniversity Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.
Psychology of sport and exercise
|November 12, 2025
概括
同时的认知运动双任务 (CMDT) 训练显著改善了老年人的执行功能 (EF) 和功能能力. 这种结合体力和认知方法为老年人群提供了比单独的传统训练更大的好处.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 运动学 运动学
背景情况:
- 执行功能 (EF) 如抑制,工作记忆和认知灵活性随着年龄的增长而下降,增加跌倒风险和减少独立性.
- 传统的身体干预 (有氧,抵抗,协调训练) 在改善老年人EFS方面显示出混合的结果.
研究的目的:
- 评估同时进行认知运动双任务 (CMDT) 培训对提高老年人群执行功能和功能能力的有效性.
- 将CMDT训练与传统的身体和认知训练方法进行比较.
主要方法:
- 系统性审查和元分析被用来综合CMDT培训的证据.
- 同时CMDT涉及同时执行身体和认知任务,利用共享的认知和运动资源.
主要成果:
- 与单独的身体或认知训练相比,同时进行CMDT训练始终显示出EF和双任务性能的优异改进.
- 这种培训增强了移动性,降低了跌倒风险,并改善了老年人的功能独立性.
结论:
- 同时的CMDT是一种高效和生态有效的干预措施,用于保护老年人群的认知和功能能力.
- 需要进一步研究最佳训练参数,如频率,持续时间和强度,并对临床组进行潜在应用.
相关概念视频
Cognitive Development During Adulthood
757
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
757
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
527
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
527
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180


